Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bausch Health Companies Inc (NY: BHC ) 7.820 -0.270 (-3.34%) Official Closing Price Updated: 7:00 PM EDT, May 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Bausch Health Companies Inc < Previous 1 2 3 4 5 Next > Bausch Health Announces First Quarter 2024 Results May 02, 2024 Via ACCESSWIRE Bausch Health to Announce First-Quarter 2024 Results on May 2 April 11, 2024 Via ACCESSWIRE Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich’s Abbreviated New Drug Application Until 2029 April 11, 2024 Via ACCESSWIRE Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan April 11, 2024 Via ACCESSWIRE Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals April 05, 2024 Via ACCESSWIRE Salix Announces 2024 Gastrointestinal Health Scholars Program February 12, 2024 Via ACCESSWIRE CORRECTION BY SOURCE: Solta Medical's Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China January 18, 2024 Via ACCESSWIRE Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults April 03, 2024 Via ACCESSWIRE Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations April 02, 2024 Via ACCESSWIRE Salix Pharmaceuticals Announces a Phase 2 Investigator-Initiated Study of RELISTOR(R) (methylnaltrexone bromide: MNTX) in Patients with Resectable Head and Neck Squamous Cell Carcinoma March 06, 2024 Via ACCESSWIRE New Survey Finds More Than Half of Past U.S. Colonoscopy Patients Wish They Had Known More Information About Colonoscopies Including Prep Medication Options and How To Prepare for the Procedure March 05, 2024 Via ACCESSWIRE Bausch Health Companies to Present at Cowen Annual Health Care Conference March 01, 2024 Via ACCESSWIRE Solta Medical’s Thermage(R) FLX and TR-4 Return Pad Receive Registration Certifications in China January 18, 2024 Via ACCESSWIRE Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis December 21, 2023 Via ACCESSWIRE Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD) October 26, 2023 Via ACCESSWIRE Bausch Health Announces Fourth-Quarter and Full-Year 2023 Results February 22, 2024 Via ACCESSWIRE Bausch Health Announces Board Refreshment February 01, 2024 Via ACCESSWIRE Bausch Health to Announce Fourth-Quarter and Full-Year 2023 Results on Feb. 22 February 01, 2024 Via ACCESSWIRE CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S. January 30, 2024 Via ACCESSWIRE Court of Appeals for the Federal Circuit Hears Oral Arguments on Patent Dispute January 07, 2024 Via ACCESSWIRE DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan December 18, 2023 Via ACCESSWIRE 3 cheap 'stock'-ing stuffers Wall Street is bullish on December 07, 2023 These three companies have Wall Street feeling bullish and are trading under $10, making them ideal ‘stock'-ing stuffers for hard to shop for traders. Via MarketBeat Topics Stocks Exposures US Equities Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day December 05, 2023 Via ACCESSWIRE Bausch Health Companies Inc. (NYSE:BHC) Long Term Shareholder Notice: Investigation of Potential Wrongdoing December 01, 2023 San Diego, CA -- (SBWIRE) -- 12/01/2023 -- An investigation on behalf of current long-term investors in shares of Bausch Health Companies Inc. (NYSE:BHC) concerning potential breaches of fiduciary... Via SBWire The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis November 10, 2023 Via ACCESSWIRE CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis November 10, 2023 Via ACCESSWIRE As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD) November 08, 2023 Via ACCESSWIRE Bausch Health Announces Third-Quarter 2023 Results November 02, 2023 Via ACCESSWIRE U.S. District Court Dismisses Norwich's Lawsuit Against the FDA November 01, 2023 Via ACCESSWIRE FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older October 20, 2023 Via ACCESSWIRE < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.